title: Use of proteomic analysis tools to identify HCV-proteins down-regulated by acetylsalicylic acid.
abstract: Background and aim. Acetylsalicylic acid (ASA) has been shown to downregulate HCV expression; however, the involved mechanisms are unknown. We used proteomic analysis to compare protein expression profiles between human hepatocarcinoma cells (Huh7) and Huh7-HCV cells harboring expression of non-structural HCV proteins, to elucidate the mechanism(s) involved in ASA-mediated downregulation of HCV replication. Material and methods. Both cell lines were treated or untreated with 4 mM ASA and harvested at 0, 24, 48 and 72 h to isolate total proteins, which were resolved by two-dimensional gel electrophoresis (2DE) to separate them by isoelectric point (pI), followed by fractionation by molecular weight (MW). Gels were scanned and analyzed with PD-Quest software V8.0.1, and proteins were elucidated by the specific pI and MW using TAGIDENT software. Statistics analysis included the t-test. esults and Discussion. Different protein patterns among hepatocytes expressing HCV-proteins in ASA treated and untreated cells were found. Among proteins differentially expressed in Huh7-HCV cells, we found proteins related to cell proliferation (MTMR6, FAM22, HDGF and HCF-1) after 24 h of ASA treatment; and upregulation of angiostatin, PI4KA and STAT-1 after 48 h of treatment. Finally, at 72 h of ASA exposure, we identified overexpression of adenylsuccinate synthase, 2'-3'-di-deoxyadenosine, ubiquitin-protein-ligase E6A, adenylosuccinate-lyase and nibrin (NBN). Conclusion. We found that ASA induces different protein patterns in Huh7-HCV cells promoting activation of proteins involved in cell progression, repair of double strand breaks, proliferation, inhibition of apoptosis and growth stimulation at the same time that it decreased HCV expression.
authors.affiliation: Departments of Biochemistry and Molecular Medicine and.
authors.forename: Adriana
authors.initials: A
authors.lastname: Sánchez-García
authors.forename: Clara Patricia
authors.initials: CP
authors.lastname: Ríos-Ibarra
authors.forename: Ana Rosa
authors.initials: AR
authors.lastname: Rincón-Sánchez
authors.forename: Rocío
authors.initials: R
authors.lastname: Ortiz-López
authors.forename: Aurora
authors.initials: A
authors.lastname: Garza-Juárez
authors.forename: Jesús
authors.initials: J
authors.lastname: Morlett-Chávez
authors.forename: Herminia
authors.initials: H
authors.lastname: Martínez-Rodríguez
authors.forename: Ana María
authors.initials: AM
authors.lastname: Rivas-Estilla
mesh_terms: D000998:Antiviral Agents / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology*; D045744:Cell Line, Tumor; D015536:Down-Regulation; D015180:Electrophoresis, Gel, Two-Dimensional; D016174:Hepacivirus / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D007525:Isoelectric Focusing; D040901:Proteomics / Q000379:methods; D013997:Time Factors; D014764:Viral Proteins / Q000378:metabolism*
chemical_list: D000998:Antiviral Agents; D014764:Viral Proteins; D001241:Aspirin